# Ipsen (stock symbol: IPN.PA) Logo in transparent PNG and SVG formats

## Ipsen Logo large

### Ipsen Logo large Download PNG (50.96 KB)

![Ipsen Logo large Download PNG (50.96 KB)](/img/orig/IPN.PA_BIG-8fd675d1.png)

### Ipsen Logo large Download SVG (9.91 KB)

![Ipsen Logo large Download SVG (9.91 KB)](/img/orig/IPN.PA_BIG-b1ea19f1.svg)

## Ipsen Logo icon format

### Ipsen Logo icon format Download PNG (55.98 KB)

![Ipsen Logo icon format Download PNG (55.98 KB)](/img/orig/IPN.PA-a1561afb.png)

### Ipsen Logo icon format Download SVG (975 Bytes)

![Ipsen Logo icon format Download SVG (975 Bytes)](/img/orig/IPN.PA-3fedffa1.svg)

## Ipsen Logo large for dark backgrounds

### Ipsen Logo large for dark backgrounds Download PNG (26.06 KB)

![Ipsen Logo large for dark backgrounds Download PNG (26.06 KB)](/img/orig/IPN.PA_BIG.D-053ea1e1.png)

### Ipsen Logo large for dark backgrounds Download SVG (7.55 KB)

![Ipsen Logo large for dark backgrounds Download SVG (7.55 KB)](/img/orig/IPN.PA_BIG.D-9f499cb8.svg)

## Ipsen Logo icon format for dark backgrounds

### Ipsen Logo icon format for dark backgrounds Download PNG (33.35 KB)

![Ipsen Logo icon format for dark backgrounds Download PNG (33.35 KB)](/img/orig/IPN.PA.D-497cc058.png)

### Ipsen Logo icon format for dark backgrounds Download SVG (950 Bytes)

![Ipsen Logo icon format for dark backgrounds Download SVG (950 Bytes)](/img/orig/IPN.PA.D-aa271fd1.svg)

## About Ipsen

Ipsen S.A. operates as a biopharmaceutical company worldwide. The company provides drugs in the areas of oncology, neuroscience, gastroenterology, cognitive disorders, and rare diseases. It offers Somatuline for neuroendocrine tumors and acromegaly; Decapeptyl for the treatment of advanced metastatic prostate cancer; Cabometyx for renal cell and second-line hepatocellular carcinoma; Onivyde for second-line metastatic pancreatic cancer; Dysport for motor muscular disorders and medical aesthetics; NutropinAq for growth failure in children due to growth hormone (GH) deficiency, turner syndrome, chronic renal failure, and GH deficiency in adults; and Increlex for growth failure in children and adolescents. The company also offers Smecta for chronic and acute diarrhea, and pain associated with functional bowel diseases; Forlax for constipation; Fortrans/Eziclen for bowel cleansing prior to endoscopy, X-ray examination, and colonic surgery; and Tanakan for cognitive disorders in adults, vertigo of vestibular origin and vestibular rehabilitation, and tinnitus. In addition, it provides Xermelo for the carcinoid syndrome; Cometriq for medullary thyroid cancer; Smebiocta/SmectaFlora Protect, a food supplement; SmectaGas, a medical device used in the symptomatic treatment of gas-related gastrointestinal disorders and relief of gas-related symptoms; and Etiasa for inflammatory bowel diseases. Further, the company offers other consumer healthcare products in the gastro-intestinal area, including Buscopan, Clin4000, Prontalgine, Suppositoria Glycerini, Mucothiol, Floractin, and Mucodyne. Ipsen S.A. has agreements with Debiopharm; Exelixis; Galderma; Blueprint Medicines; TerSera Therapeutics; Rhythm Pharmaceuticals; Teijin; Braintree Laboratories; Ethypharm; Schwabe; BAKX Therapeutics Inc.; and Exicure. The company was founded in 1929 and is headquartered in Boulogne-Billancourt, France.

1. Website domain: ipsen.com
2. Employees: 4500
3. Marketcap: $9.80 Billion USD


## Categories
- [x] ðŸ‡«ðŸ‡· France
- [x] ðŸ’Š Pharmaceuticals
- [x] ðŸ§¬ Biotech
